Tarsons Products Hits New 52-Week Low at Rs. 281.15

Tarsons Products, a small-cap player in the healthcare services industry, has reached a new 52-week low of Rs. 281.15 today, marking a significant downturn for the stock. This decline comes as the company has underperformed its sector by 2.34%, continuing a streak of four consecutive days of losses, during which it has seen a total drop of 2.35%. The stock's performance has been notably weak over the past year, with a staggering decline of 32.66%, contrasting sharply with the Sensex's positive return of 3.95% during the same period. Tarsons Products is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a persistent downward trend. In addition to the price drop, the company has reported a low Return on Capital Employed (ROCE) of 8.12%, reflecting challenges in profitability. Furthermore, institutional investors have reduced their stakes by 3.27% in the last quarter, now holding only 5.91% of the company. This combination of factors has contributed to the stock's current position in the market.